Evidence map›Paper›PMID 36406945›Full record

ReviewJournal of clinical medicine research2022

Type 5 Cardiorenal Syndrome: An Underdiagnosed and Underrecognized Disease Process of the American Mother.

Justin Ilagan, Harshini Sahani, Arif Bin Saleh, Kameron Tavakolian, Anton Mararenko, Ndausung Udongwo, Steven Douedi, Vandan Upadhyaya, Swapnil Patel, Arman Mushtaq and 3 more

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Justin IlaganDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
Harshini SahaniDepartment of Obstetrics and Gynecology, Monmouth Medical Center, Long Branch, NJ 07740, USA.
Arif Bin SalehDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
Kameron TavakolianDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
Anton MararenkoDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
Ndausung UdongwoDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
Steven DouediDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
Vandan UpadhyayaDepartment of Cardiovascular Disease, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
Swapnil PatelDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
Arman MushtaqDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
Brett SealoveDepartment of Cardiovascular Disease, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
David GonzalezDepartment of Maternal and Fetal Medicine, Monmouth Medical Center, Long Branch, NJ 07740, USA.
Arif AsifDepartment of Internal Medicine, Jersey Shore University Medical Center, Neptune City, NJ 07753, USA.
Jersey Shore University Medical Center · USMonmouth Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiorenal syndrome (CRS) continues to be an area of concern due to the changing understanding of identification, pathophysiology and optimal management. Originally thought that diuretics were always the answer, recent literature has shed lights on the five major CRS subphenotypes, and while conceptual in their classifications, different strategies may be utilized to manage each type. The effect of CRS in pregnant women is largely under discussed and underappreciated as its own entity. Trials involving possible management, specifically utilizing serelaxin, a recombinant form of relaxin, have shown promising results but more data are needed to begin implementing it on a large scale.

Indexed as

Cardiorenal syndromePregnant womenSerelaxinType 5

Identifiers

PMID36406945
PMCPMC9635802
OpenAlexW4307710737

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.